All In Biotech

Drug Trial Radar · NCT00704847

Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)

A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects With Knee Osteoarthritis

Last checked: Nov 19, 2026Latest source record: Apr 24, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,030 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

1,030

Actual

Start

Jun 2008

Primary completion

May 2011

Study completion Jun 2011

Sponsor

Lead sponsor
Nordic Bioscience A/SIndustry
Sponsor type
Industry
Collaborators
Novartis
First posted
Jun 25, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 51 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this phase III study is to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Patients with Osteoarthritis of the Knee

Conditions

  • Osteoarthritis

Interventions

  • Oral Salmon CalcitoninDrug

    0.8mg SMC021, twice daily

  • Oral Salmon Calcitonin (Placebo)Drug

    0.8mg Placebo, twice daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Joint Space Width (JSW) in the Medial Tibia-femoral Knee Joint in the Signal Knee Measured by X-ray Change From Baseline Over 24 MonthsTime frame: Change from baseline to 24 months
  2. Pain Subscore Change From Baseline Over 24 Months as Assessed by Western Ontario and McMaster Universities Arthritis (WOMAC) IndexTime frame: Change from baseline to 24 months

Locations

18 sites in 10 countries. Site status is shown where the registry gives one.

  • Achieve Clinical Research, LLC

    Tuscaloosa, Alabama

  • Center for Healthy Aging

    Sacramento, California

  • Northwestern Center for Clinical Research

    Chicago, Illinois

  • Midwest Pharmaceutical Research

    City of Saint Peters, Missouri

  • Thurston Arthritis Research Center

    Chapel Hill, North Carolina

  • Rheumatology Clinical Research Unit

    Beachwood, Ohio

  • Hospital Universitaire St. Luc, UCL 5390

    Brussels, Belgium

  • Centre de Rhumatologie St-Louis

    Sainte-Foy (Québec), Canada

  • CCBR Czech

    Pardubice, Czechia

  • CCBR Aalborg

    Aalborg, Denmark

  • CCBR Ballerup

    Ballerup Municipality, Denmark

  • CCBR Vejle

    Vejle, Denmark

  • CCBR Hong Kong

    Hong Kong, Hong Kong

  • Centrum Osteoporozy i Chorób Kostno Stawowych, ul. Waryńskiego 6/2

    Bialystok, Poland

  • CCBR Poland

    Warsaw, Poland

  • CCBR Romania

    Bucharest, Romania

  • Hospital Universitario de la Paz

    Madrid, Spain

  • Little Common Surgery

    Bexhill-on-Sea, East Sussex, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.